Studies were identified through PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) using the operator AND in combination with search terms including: air pollution/fine particulate matter (PM2.5), oxidative stress, oxidative stress genes/polymorphisms, dietary antioxidants, effect modification, respiratory health, and cardiovascular health.
In addition, advice on lifestyle modifications and regular cardiovascular risk factor assessment are required as part of survivorship programs to minimize cardiovascular morbidity and mortality in this population.
In separate analyses, we assessed potential effect modification between maternal height and cardiovascular risk factors, but found no consistent evidence of any interaction (all P-values above 0.10, except for HDL cholesterol with p=0.03) (results not shown).
These subjects, together with 200 high risk individuals in the UK from the RCT will form the cohort of 600 subjects to enable the study of the relationship between markers of sub-clinical atherosclerosis (cIMT, endothelial function and arterial stiffness), and albumin excretion and its modification by cardiovascular risk factors, renal function and diabetes control.
17, 18 In response to data from focus groups held during development, the UKPDS data were supplemented with data from Cochrane or Health Technology Assessment systematic reviews or large randomised controlled trials that reported the effects of medication and behavioural modification on cardiovascular disease outcomes (rates of myocardial infarction and stroke) and mortality rates.
Additionally, it has been postulated that therapeutic interventions and cardiovascular risk modification can influence myocardial blood flow or flow reserve of the heart [ 20– 20].
In four different rat models of renal injury and of cardiovascular injury, it improves renal and cardiovascular lesions without modification of blood pressure.
Tables 2 and 3 show the difference in demographics, glycemic control, and cardiovascular risk factor modification between patients with type 1 and type 2 diabetes.
Our study adds to the literature by describing attainment of glycemic and cardiovascular risk factor modification targets in a young adult population.
Despite the overwhelming evidence that improving glycemic control and cardiovascular risk factor modification improves outcomes for patients with type 1 and type 2 diabetes, most patients do not achieve recommended treatment targets.
